GSK•benzinga•
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Summary
Sanofi reveals Phase 2 results for rilzabrutinib in moderate-to-severe asthma. High and low doses showed a reduction in asthma control loss events and symptom improvements.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 22, 2024 by benzinga